Well said. I was thinking the same about the CR. IMO it wasn't a mistake it had to happen and was just a matter of when. There was never going to be a good time, it was strategic and the best time that it could happen. All over and now not thinking about funding just getting through trials - hopefully with amazing results.
I'm glad they did it when they did instead of leaving it. It would be getting funded at 6c or 7c if they'd left it!
Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-56
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 160000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11013 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
